NeuroBo Pharmaceuticals | EFFECT: Others
Apr 24 06:08 ET
NeuroBo Pharmaceuticals | 424B3: Prospectus
Feb 1, 2023 17:25 ET
NeuroBo Pharmaceuticals | EFFECT: Others
Feb 1, 2023 00:15 ET
NeuroBo Pharmaceuticals | 424B4: Prospectus
Nov 7, 2022 09:07 ET
NeuroBo Pharmaceuticals | EFFECT: Others
Nov 7, 2022 00:15 ET
NeuroBo Pharmaceuticals | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
Oct 24, 2022 16:38 ET
NeuroBo Pharmaceuticals | 424B5: Prospectus
Oct 4, 2021 16:31 ET
NeuroBo Pharmaceuticals | EFFECT: Others
May 27, 2021 00:15 ET
NeuroBo Pharmaceuticals | EFFECT: Others
May 3, 2021 00:15 ET
NeuroBo Pharmaceuticals | 424B3: Prospectus
Apr 30, 2021 17:13 ET
NeuroBo Pharmaceuticals | 424B3: Prospectus
Feb 1, 2021 16:19 ET
NeuroBo Pharmaceuticals | EFFECT: Others
Feb 1, 2021 00:15 ET
NeuroBo Pharmaceuticals | 424B3: Prospectus
Jan 29, 2021 09:20 ET
NeuroBo Pharmaceuticals | 424B5: Prospectus
Apr 15, 2020 17:19 ET
NeuroBo Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Dec 30, 2019 11:22 ET
NeuroBo Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Dec 6, 2019 16:01 ET
NeuroBo Pharmaceuticals | EFFECT: Others
Nov 7, 2019 00:15 ET
NeuroBo Pharmaceuticals | 424B3: Prospectus
Nov 6, 2019 09:15 ET
NeuroBo Pharmaceuticals | S-4/A: Registration of securities issued in business combination transactions (Amendment)
Nov 4, 2019 16:23 ET
NeuroBo Pharmaceuticals | S-4/A: Registration of securities issued in business combination transactions (Amendment)
Oct 29, 2019 21:34 ET
No Data
No Data